| Management target | Revenue FY28 |
|---|
| Revenue growth | 20.4% YoY growth; organic growth in core research solutions up 26.3%. |
|---|---|
| Margins | Expanding to 34.3% from 27% YoY due to structural efficiency. |
| Demand visibility | Strong forward visibility through recurring subscription models in Unbound Medicine. |
| Management confidence | Extremely high; focusing on rule of 50 and compounding growth. |
Growth
Revenue grew 20% YoY, while EBITDA surged 53% driven by 34.3% margins. Operating leverage is strong with headcount rising only 3%.
Outlook
Management reaffirmed target of crossing 300 Cr EBITDA in FY27 and 1,500 Cr revenue by FY28.
Risks
Pruning of AJEE segment to improve quality over volume results in lower segment revenue. Rapid AI adoption creates valuation and obsolescence risks.
Last quarter's promises, checked
Delivered
- Guided 100 Cr+ EPS in FY26 → delivered 102.11 Cr (= BEAT)
- Guided FY26 record profitability → delivered record 236 Cr EBITDA (= BEAT)
- Guided Q4 exit margin turnaround in Corporate Learning → delivered 26.3% margin vs 16.5% FY average (= BEAT)
Partly delivered
- Guided Unbound Medicine FY27 exit margin 25-30% → current margin 18-19% (= PARTIAL)
Earnings Call Transcript filed with NSE, NSE: MPSLTD. Summary written with AI assistance from the document.
MPS Ltd: key numbers
- Share price
- ₹2,666.90
- Market cap
- ₹4,562 Cr
- Revenue (annual)
- ₹768.4 Cr
- Net profit (annual)
- ₹173.2 Cr
- P/E (TTM)
- 24.2×Sector 41.4×
- Promoter holding
- 68.34%+0.00% QoQ
- FII holding
- 1.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from MPS Ltd
All →MPS Acquisition
MPS Limited informed the exchange that the NCLT has passed an order regarding the second motion petition for its amalgamation with ADI BPO Services Limited.
MPS Other Announcement
MPS Limited has received an unsolicited 'CRISIL ESG 64 (Strong)' rating from CRISIL ESG, based on publicly available data without company engagement.
MPS Annual General Meeting
MPS Limited conducted its 56th Annual General Meeting on September 4, 2026. This document provides the summary of proceedings and resolutions discussed during the meeting.
MPS Investor Presentation: Key Takeaways
MPS reports record Q1 FY27 results with 20.38% revenue growth and 53.03% EBITDA surge, driven by the Unbound Medicine acquisition and AI-enabled workflows.
MPS Q1 FY27 Results: Net Profit ₹50.4 Cr, Up 43.2% YoY
MPS Ltd reported revenue from operations of ₹224.2 Cr (+20.3% YoY) and net profit of ₹50.4 Cr (+43.2% YoY) for Q1 FY27.
- Key figure
- Net profit ₹50.4 Cr · +43.2% YoY
MPS Earnings Call: Key Takeaways
MPS Limited reports FY26 as its most profitable year, driven by AI-led knowledge solutions and the acquisition of Unbound Medicine.